Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Low
155.00
High
350.95
Low
318.15
High
332.50
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Marksans Pharma Limited stacks up against its Drug Manufacturers - General peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MARKSANS Marksans Pharma Limited | 323.05 | 0.23% | 28.32 | 11.41 | 14,719 | 1.00% | 90.70% | 350.95 / 155.00 |
| 2 | CORONA CORONA REMEDIES LIMITED | 2,021.10 | 3.45% | 62.11 | 32.54 | 12,412 | 5.96% | 42.93% | 2,292.40 / 1,336.60 |
| 3 | GLAXO GlaxoSmithKline Pharmaceuticals Limited | 2,760.00 | 0.34% | 43.77 | 63.05 | 46,965 | 6.56% | 0.93% | 3,120.70 / 2,088.10 |
| 4 | NGLFINE NGL Fine-Chem Limited | 2,900.00 | 0.33% | 31.27 | 92.73 | 1,792 | 1.19% | 102.51% | 3,602.00 / 1,271.00 |
| 5 | PFIZER Pfizer Limited | 3,857.00 | 0.47% | 24.00 | 160.70 | 17,654 | 20.77% | 25.83% | 5,578.50 / 3,792.10 |
| 6 | RUBICON RUBICON RESEARCH LIMITED | 1,628.00 | 0.53% | 93.28 | 17.45 | 26,949 | 8.34% | 159.03% | 1,899.00 / 570.75 |
| 7 | SAIPARENT SAI PARENTERALS LIMITED | 522.80 | 1.23% | 106.53 | 4.91 | 2,310 | 0.43% | 28.40% | 706.00 / 400.00 |
| 8 | SANOFI Sanofi India Limited | 3,040.00 | 0.56% | 21.62 | 140.59 | 6,995 | 7.23% | 40.91% | 4,898.00 / 3,001.10 |
| 9 | SANOFICONR SANOFI CONS HEALTHC IND L | 3,775.20 | 0.73% | 32.68 | 115.51 | 8,722 | 10.15% | 26.46% | 5,255.00 / 3,691.00 |
| 10 | SENORES SENORES PHARMACEUTICALS L | 1,335.30 | 3.64% | 49.39 | 27.03 | 6,150 | 11.45% | 93.48% | 1,599.00 / 684.60 |
| 11 | SMSPHARMA SMS Pharmaceuticals Limited | 470.95 | 1.19% | 42.23 | 11.15 | 4,411 | 32.98% | 98.04% | 494.45 / 245.21 |
| 12 | TTKHLTCARE TTK Healthcare Limited | 1,012.20 | 1.06% | 19.34 | 52.34 | 1,431 | 7.52% | 14.00% | 1,247.00 / 735.00 |